OraSure patent settlement
This article was originally published in The Gray Sheet
Executive Summary
OraSure Technologies will pay $3 million to Inverness to settle a patent infringement lawsuit, the firm announces Nov. 19. The settlement grants OraSure non-exclusive licenses to lateral flow technology patents for the OraQuick HIV-1/2 test and HCV test. In addition, each party has received distribution rights to certain products supplied by the other party, for certain markets, according to OraSure